DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Vision - To eliminate ovarian cancer

Ovarian Cancer Research Program Cover Image
» Click on Image to View Research Update

Lung Cancer Research Program Cover Image
» Click on Image to View Strategic Plan

The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) was initiated in FY97 to support high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the research development pipeline from basic to translational to clinical research, including clinical trials, and to push the field of ovarian cancer forward through our vision to “Eliminate ovarian cancer”. Our current research priorities include:

  • Promoting readiness for military members and their families as well as the overall health of citizens of the United States and the world
  • Utilizing precision medicine approaches that identify individual tumor characteristics to optimize patient care and outcomes
  • Enhancing the pool of ovarian cancer scientists
  • Promoting research that will improve access to quality care, and the physical and psychosocial well-being of those diagnosed with ovarian cancer
  • Developing or improving performance and reliability of screening and diagnostic approaches
  • Understanding the precursor lesion/stem cell, microenvironment, and pathogenesis/ progression of all types of ovarian cancer, including rare subtypes
  • Developing and validating models to study initiation, progression, metastasis, and recurrence of ovarian cancer
  • Promoting research that focuses on cancer risk and primary prevention
  • Investigating tumor response to therapy, including tumor survival, dormancy, cell death, clonal evolution, and resistance
  • Reduce the incidence of ovarian cancer and improve outcomes

Ovarian cancer is fifth leading cause of cancer-related death in women and the deadliest of gynecologic cancers. In 2018 approximately 22,240 women will be diagnosed with ovarian cancer in the United States, and an estimated 14,070 will die from the disease. Ovarian cancer accounts for just 2.5% of all female cancer cases, but 5% of cancer deaths because of the disease’s low survival.1 American Cancer Society has posted a “Special Section: Ovarian Cancer” at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-special-section-ovarian-cancer-2018.pdf

September is Ovarian Cancer Awareness month. Help raise awareness of the risks, signs, and symptoms of this disease by wearing TEAL!

1 American Cancer Society, https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html.


Congressional Appropriations

Congressional Appropriations

  • $296.5 million
    FY97-FY17
  • $20.0 million
    FY18

Funding Summary

Funding
Summary


Alternate Text

Ovarian Cancer Research Funding Directory

Ovarian Cancer Academy

Inspiring a New Generation of Ovarian Cancer Researchers

news_icon News & Highlights

Vision

To eliminate ovarian cancer

Mission

To support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service Members, Veterans, retirees, their family members, and all women impacted by this disease

Last updated Monday, August 20, 2018